Market Cap

PainReform Ltd. Market Capitalization:

$38,647

USD as of Jan. 1, 2024

business PainReform Ltd. Company Profile

PainReform Ltd. Main Stock Listing

NASDAQ: PRFX

Market Capitalization History of PainReform Ltd.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—Specialty & Generic
Company Market Cap (USD)
Zoetis Inc. $89.09 B
MERCK Kommanditgesellschaft auf Aktien $67.64 B
Takeda Pharmaceutical Company Limited $47.71 B
Haleon plc $38.90 B
PPD, Inc. $16.58 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of PainReform Ltd. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $38,647 -27.34%
Jan. 1, 2023 $53,192 -54.55%
Jan. 1, 2022 $117,022 -75.66%
Jan. 1, 2021 $480,858

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

PainReform Ltd. Categories

Israel languages Healthcare languages Drug Manufacturers—Specialty & Generic
Israel Healthcare Israel Drug Manufacturers—Specialty & Generic

Stocks & Indices

PainReform Ltd. has the following listings and related stock indices.


Stock: NASDAQ: PRFX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.